Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 355 results found. Search for [ coronavirus treatment research ]

Results 1 to 21 of 355
BusinessToday.In
May 11, 2021
Scientists from the UK, Italy, Spain and Japan claim a significant reduction in mortality, time to recovery and viral clearance in COVID-19 patients treated with Ivermectin but WHO has recommended against its general use


BusinessToday.In
May 10, 2021
Baricitinib was issued a restricted emergency use approval by the health ministry's CDSCO for the use in combination with Remdesivir for treatment of Covid-19


BusinessToday.In
May 9, 2021
The Gujarat government has set up separate wards for the treatment of 'Black Fungus' cases in all civil hospitals, especially in Ahmedabad, Bhavnagar, Jamnagar Rajkot, Surat, and Vadodara


BusinessToday.In
May 6, 2021
RBI Governor Shaktikanta Das announced had a Rs 50,000 lending programme to ramp up COVID-19-related healthcare infrastructure amid massive second wave ravaging India


BusinessToday.In
May 5, 2021
Principal Scientific Advisior K VijayRaghavan emphasised on upgrading the vaccines to fight against new variants of SARS-CoV-2 virus; He suggested preparing a map of all possible changes due to coronavirus


BusinessToday.In
May 4, 2021
Bajaj Healthcare Limited (BHL) has received approval from India's drug regulator, to manufacture and market 'Favijaj' in India for the treatment of COVID-19 from May 4, 2021, onwards


BusinessToday.In
May 3, 2021
Natco will now request a \"compulsory license\" based on emergency use and in light of the grave and serious public health emergency across India due to the Covid-19 pandemic


Akarsh Verma
New Delhi, April 25, 2021
New clinical research by scientists of Weill Cornell Medicine is trying to determine whether video game-based therapy can help recover COVID-19 patients with cognitive disorder symptoms.


Rashi Bisaria
New Delhi, April 12, 2021
India bans Remdesivir exports till COVID surge abates India has banned the export of Remdesivir injection and active pharmaceutical ingredients (API) used for making the coronavirus medication till the recent surge in COVID-19 cases subsides. India has been witnessing a surge in COVID-19 cases with the second wave of the pandemic. As of Sunday, the number of active cases stood at 11.08 lakh. This has led to a sudden spike in demand for Injection Remdesivir used in treatment of COVID patient...


PTI
April 4, 2021
The meeting came on a day India recorded 93,249 new coronavirus infections, the highest single-day rise so far this year that took the total COVID-19 cases to 1,24,85,509


PB Jayakumar
March 31, 2021
Hemmo is one of the few pure-play synthetic peptide API manufacturers in the global marketplace. It has R&D capabilities and a world-class GMP manufacturing facility at Thurbhe in Navi Mumbai


Associated Press
March 31, 2021
Health Minister Jens Spahn and state officials agreed unanimously to only give the vaccine to people aged 60 or older, unless they belong to a high-risk category for serious illness from COVID-19


PTI
February 22, 2021
The company, which has its labs in England, had in early September 2020 received the approval from the Drug Controller General (DCGI) to conduct the phase 2 clinical trial of GPP-Baladol in patients with moderate infection of the pandemic with oxygen support


BusinessToday.In
February 19, 2021
Stock Market News Updates Today: Bajaj Finserv, IndusInd Bank, RIL, Kotak Bank were among the top gainers today, while NTPC, PowerGrid, Asian Paints, ICICI Bank, Tata Motors were among the top losers


BusinessToday.In
February 18, 2021
Stock Market News Updates Today: ONGC, SBI, Power Grid, RIL, NTPC, ITC, Tech Mahindra, Infosys, RIL, TCS and IndusInd Bank were among the top gainers. On the other hand, Axis Bank, Bajaj Finserv, HDFC Bank, HUL, HDFC, Airtel and L&T were among the top losers today


BusinessToday.In
February 17, 2021
National Intelligence Service (NIS), the chief intelligence agency of South Korea informed lawmakers about the alleged cyber breach on Tuesday, February 16, during a closed-door briefing to a parliamentary intelligence committee


BusinessToday.In
February 1, 2021
Union Budget 2021 Highlights: Congress leader P. Chidambaram said that the government had only marginally raised health funding, which when adjusted to inflation becomes nil


Rajeev Dubey | Vivek Punj
January 11, 2021
Full authorisation-better known as \"full pre-qualification\"-is a pre-requisite to sell the vaccine in the open market or for mass immunisation of healthy individuals who are not frontline workers


BusinessToday.In
December 29, 2020
It is important from the scientific community perspective that we do not put too much immune pressure on the virus, said Bhargava


PTI
December 27, 2020
Tthe researchers in the Storm Chase study believe a Long-Acting AntiBody (LAAB) known as AZD7442, developed by AstraZeneca, may offer immediate and long-term protection to people who have been recently exposed to coronavirus


PAGES 1 OF 18  12345